Essential Biomarker Testing in GI Cancers - a podcast by Clinical Care Options

In this episode, John L. Marshall, MD, discusses current molecular testing considerations in the treatment of patients with gastrointestinal tumors, including:

• Current testing approaches, including IHC and PD-L1 assays and next-generation sequencing
• Tumor agnostic testing: MSI, TMB, and NTRK fusion testing
• Colon cancer: RAS, BRAF, and HER2
• Gastric cancer: PD-L1, HER2, and more
• Pancreatic cancer: BRCA
• Biliary cancers: FGFR and IDH1
• Liquid biopsies
• When to test

Presenter:

John L. Marshall, MD
Chief, Division of Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Content based on an online CME program supported by educational grants from Bayer and Merck, Sharp & Dohme.

Link to full program:
https://bit.ly/3j4hV8J

Further episodes of CCO Oncology Podcast

Further podcasts by Clinical Care Options

Website of Clinical Care Options